InsiderClue
← All stocks

10x Genomics, Inc.

TXG Net selling
CIK 0001770787 #1039 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$14.38M
$7.09M on a plan · $0.00 straight out of an exercise
Sold at will
$7.29M
16 of 40 sales
Net
−$14.38M
−$7.29M against sales at will

By person

9 insiders · 41 transactions
111×

Serge Saxonov holds 111 times base salary in stock. $74.84M of shares against $674.25K in salary for 2025.

Salary from the company's own proxy. The shares are what Serge Saxonov last reported holding, valued at $65.26, the price Class A Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Taich Adam
Chief Financial Officer
—
$4.84M (7) scheduled
−$4.84M
316,344
0.2477%
$20.64M
—
Saxonov Serge
Chief Executive Officer
—
$4.79M (17) scheduled
−$4.79M
1,146,893
0.8982%
$74.84M
+26.6%
STUELPNAGEL JOHN R
Director
—
$2.39M (5)
−$2.39M
328,436
0.2572%
$21.43M
−4.6%
Hindson Benjamin J.
See Remarks
—
$1.46M (4)
−$1.46M
488,182
0.3823%
$31.86M
+41.2%
Teichmann Sarah A.
Director
—
$579.39K (3) scheduled
−$579.39K
28,058
0.0220%
$1.83M
+47.7%
SULIMAN SHEHNAAZ
Director
—
$327.23K (4) scheduled
−$327.23K
29,515
0.0231%
$1.93M
+122.6%
MATEO ALAN
Director
—
—
—
85,877
0.0673%
$5.60M
+295.9%
Kosaraju Sridhar
Director
—
—
—
65,278
0.0511%
$4.26M
+58.9%
Popovits Kimberly J
Director
—
—
—
37,445
0.0293%
$2.44M
+182.4%

Individual transactions

1
Insider
Date
Role
Action
Shares
Price
Amount
Saxonov Serge
5 Jan 2026
Chief Executive Officer
Exercised, kept
50,000
$1.20
$60.00K
Show all 41 transactions →

What was left out

Form 4 filings counted 36
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 24
Sales straight out of an exercise 0
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 463,114
History held since 12 Sep 2019